140 related articles for article (PubMed ID: 34739184)
1. CD4+ T-cell large granular lymphocytic leukemia with STAT3 mutation and neutropenia.
Hafeez S; Mnayer LO; DiGiuseppe JA
Cytometry B Clin Cytom; 2022 Mar; 102(2):168-170. PubMed ID: 34739184
[No Abstract] [Full Text] [Related]
2. T-cell large granular lymphocytic (LGL) leukemia consists of CD4
Kuwahara N; Kodaka T; Zushi Y; Sasaki M; Goka T; Maruoka H; Aoyama Y; Tsunemine H; Yamane T; Kobayashi J; Kawakami T; Ishida F; Itoh T; Takahashi T
J Clin Exp Hematop; 2019; 59(4):202-206. PubMed ID: 31866622
[TBL] [Abstract][Full Text] [Related]
3. STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia.
Qiu ZY; Fan L; Wang L; Qiao C; Wu YJ; Zhou JF; Xu W; Li JY
J Hematol Oncol; 2013 Oct; 6():82. PubMed ID: 24283217
[TBL] [Abstract][Full Text] [Related]
4. Somatic
Savola P; Brück O; Olson T; Kelkka T; Kauppi MJ; Kovanen PE; Kytölä S; Sokka-Isler T; Loughran TP; Leirisalo-Repo M; Mustjoki S
Haematologica; 2018 Feb; 103(2):304-312. PubMed ID: 29217783
[TBL] [Abstract][Full Text] [Related]
5. Assessment of clonality in T-cell large granular lymphocytic leukemia: flow cytometric T cell receptor Vβ repertoire and T cell receptor gene rearrangement.
Qiu ZY; Shen WY; Fan L; Wang L; Yu H; Qiao C; Wu YJ; Lu RN; Qian J; He GS; Xu W; Li JY
Leuk Lymphoma; 2015 Feb; 56(2):324-31. PubMed ID: 24828862
[TBL] [Abstract][Full Text] [Related]
6. LGL: a disease rediscovered.
Melenhorst JJ
Blood; 2012 Oct; 120(15):2932-3. PubMed ID: 23065007
[No Abstract] [Full Text] [Related]
7.
Qu S; Jia Y; Wang H; Ai X; Xu Z; Qin T; Pan L; Li B; Huang G; Gale RP; Xiao Z
Leuk Lymphoma; 2021 Jun; 62(6):1506-1509. PubMed ID: 33410350
[No Abstract] [Full Text] [Related]
8. Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.
Rajala HL; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
Ann Med; 2014 May; 46(3):114-22. PubMed ID: 24512550
[TBL] [Abstract][Full Text] [Related]
9. Somatic STAT3 mutations in large granular lymphocytic leukemia.
Koskela HL; Eldfors S; Ellonen P; van Adrichem AJ; Kuusanmäki H; Andersson EI; Lagström S; Clemente MJ; Olson T; Jalkanen SE; Majumder MM; Almusa H; Edgren H; Lepistö M; Mattila P; Guinta K; Koistinen P; Kuittinen T; Penttinen K; Parsons A; Knowles J; Saarela J; Wennerberg K; Kallioniemi O; Porkka K; Loughran TP; Heckman CA; Maciejewski JP; Mustjoki S
N Engl J Med; 2012 May; 366(20):1905-13. PubMed ID: 22591296
[TBL] [Abstract][Full Text] [Related]
10. High frequency of STAT3 gene mutations in T-cell receptor (TCR)γδ-type T-cell large granular lymphocytic leukaemia: implications for molecular diagnostics.
Yamane T; Kawakami T; Sekiguchi N; Kobayashi J; Ueki T; Kobayashi H; Kawakami F; Nishina S; Sakai H; Oshimi K; Higuchi Y; Nakazawa H; Ishida F
Br J Haematol; 2020 Sep; 190(5):e301-e304. PubMed ID: 32478405
[No Abstract] [Full Text] [Related]
11. Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis.
Gorodetskiy VR; Sidorova YV; Kupryshina NA; Vasilyev VI; Probatova NA; Ryzhikova NV; Sudarikov AB
Rheumatol Int; 2021 Jan; 41(1):147-156. PubMed ID: 33280072
[TBL] [Abstract][Full Text] [Related]
12. STAT3 mutations are not sufficient to induce large granular lymphocytic leukaemia in mice.
Dutta A; Yan D; Hutchison RE; Mohi G
Br J Haematol; 2018 Mar; 180(6):911-915. PubMed ID: 28025836
[No Abstract] [Full Text] [Related]
13. Prevalence of STAT3 mutations in patients with rheumatoid arthritis-associated T-cell large granular lymphocytic leukaemia and Felty syndrome.
Gorodetskiy V; Sidorova Y; Biderman B; Ryzhikova N; Vasilyev V; Sudarikov A
Clin Exp Rheumatol; 2024 Jan; 42(1):48-55. PubMed ID: 37497725
[TBL] [Abstract][Full Text] [Related]
14. The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.
Rajala HL; Olson T; Clemente MJ; Lagström S; Ellonen P; Lundan T; Hamm DE; Zaman SA; Lopez Marti JM; Andersson EI; Jerez A; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
Haematologica; 2015 Jan; 100(1):91-9. PubMed ID: 25281507
[TBL] [Abstract][Full Text] [Related]
15. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.
Jerez A; Clemente MJ; Makishima H; Koskela H; Leblanc F; Peng Ng K; Olson T; Przychodzen B; Afable M; Gomez-Segui I; Guinta K; Durkin L; Hsi ED; McGraw K; Zhang D; Wlodarski MW; Porkka K; Sekeres MA; List A; Mustjoki S; Loughran TP; Maciejewski JP
Blood; 2012 Oct; 120(15):3048-57. PubMed ID: 22859607
[TBL] [Abstract][Full Text] [Related]
16. Large granular lymphocyte leukemia serum and corresponding hematological parameters reveal unique cytokine and sphingolipid biomarkers and associations with STAT3 mutations.
Olson KC; Moosic KB; Jones MK; Larkin PMK; Olson TL; Toro MF; Fox TE; Feith DJ; Loughran TP
Cancer Med; 2020 Sep; 9(18):6533-6549. PubMed ID: 32710512
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of sensitive and quantitative STAT3 mutation analysis using next-generation sequencing in T-cell large granular lymphocytic leukemia.
Kristensen T; Larsen M; Rewes A; Frederiksen H; Thomassen M; Møller MB
J Mol Diagn; 2014 Jul; 16(4):382-92. PubMed ID: 24797340
[TBL] [Abstract][Full Text] [Related]
18. STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia.
Ohgami RS; Ma L; Merker JD; Martinez B; Zehnder JL; Arber DA
Leukemia; 2013 Nov; 27(11):2244-7. PubMed ID: 23563237
[No Abstract] [Full Text] [Related]
19. STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia.
Shi M; He R; Feldman AL; Viswanatha DS; Jevremovic D; Chen D; Morice WG
Hum Pathol; 2018 Mar; 73():74-81. PubMed ID: 29288042
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL).
Sanikommu SR; Clemente MJ; Chomczynski P; Afable MG; Jerez A; Thota S; Patel B; Hirsch C; Nazha A; Desamito J; Lichtin A; Pohlman B; Sekeres MA; Radivoyevitch T; Maciejewski JP
Leuk Lymphoma; 2018 Feb; 59(2):416-422. PubMed ID: 28633612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
